Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Xiang‐Nan Jiang"'
Autor:
Xiang‐Nan Jiang, Fang Yu, Tian Xue, Qing‐Xin Xia, Qian‐Ming Bai, Bao‐Hua Yu, Ruo‐Hong Shui, Xiao‐Yan Zhou, Xiong‐Zeng Zhu, Jun‐Ning Cao, Xiao‐Nan Hong, Xiao‐Qiu Li
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10684-10693 (2023)
Abstract Purpose Large B‐cell lymphoma with IRF4 rearrangement (LBCL, IRF4+) has been recently recognized as a specific entity that is frequently associated with young age and favorable prognosis. However, whether the good outcome of the disease is
Externí odkaz:
https://doaj.org/article/e24e1a0217d54169a97fc36fc6fe77eb
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Recent studies have demonstrated the benefits of metformin on patients with lymphomas. B-cell receptor (BCR)-PI3K-AKT pathway-dependent cholesterol synthesis may represent a positive feedback mechanism responsible for the pathogenesis of BCR-dependen
Externí odkaz:
https://doaj.org/article/cc834982c57e490da09452958ee45238
Autor:
Wan-Hui Yan, Xiang-Nan Jiang, Wei-Ge Wang, Yi-Feng Sun, Yi-Xin Wo, Zheng-Zhi Luo, Qing-Hua Xu, Xiao-Yan Zhou, Jun-Ning Cao, Xiao-Nan Hong, Xiao-Qiu Li
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
The well-established cell-of-origin (COO) algorithm categorizes diffuse large B-cell lymphoma (DLBCL) into activated B-cell-like (ABC) and germinal center B-cell-like (GCB) subgroups through gene expression profiling. We aimed to develop and validate
Externí odkaz:
https://doaj.org/article/c87f5fe56ad24a29876ab792c605dde4
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Background: B cells can function as antigen-presenting cells by presenting antigens captured by the B-cell receptor (BCR) on Class II Major Histocompatibility Complex (MHC II) to T cells. In addition, B-cells can also maintain immune homeostasis by e
Externí odkaz:
https://doaj.org/article/62c512ddb8164cf292414bca2089c16a
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0178416 (2017)
We retrospectively analysed 17 cases of anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK+, LBCL) according to the morphological, immunohistochemical, molecular and clinical features, using which we intend to elucidate the clinicopatholo
Externí odkaz:
https://doaj.org/article/6c248c5c43c44d6b9cbadaa8210f2a7d
Autor:
Xiang‐Nan Jiang, Fang Yu, Tian Xue, Qing‐Xin Xia, Qian‐Ming Bai, Bao‐Hua Yu, Ruo‐Hong Shui, Xiao‐Yan Zhou, Xiong‐Zeng Zhu, Jun‐Ning Cao, Xiao‐Nan Hong, Xiao‐Qiu Li
Publikováno v:
Cancer Medicine. 12:10684-10693
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d7475dca0dc5966da62a634705be484
https://doi.org/10.1002/cam4.5828
https://doi.org/10.1002/cam4.5828
Publikováno v:
Laboratory Investigation. 99:1418-1427
Targeting the programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) pathway represents a milestone in cancer therapy. However, the biologic features of diffuse large B-cell lymphoma (DLBCL) with PD-L1 expression remains unknown. We evaluated th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::508f46d790c0856e6fc738b0c4e680da
https://doi.org/10.1038/s41374-019-0262-5
https://doi.org/10.1038/s41374-019-0262-5
Publikováno v:
Hematological oncologyREFERENCES. 38(5)
The prognostic value of histologic grading and the Ki-67 proliferation index in follicular lymphoma (FL) is controversial. This study investigated the clinical usefulness of these two factors in Asian FL patients. Four hundred and thirty-three patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b3d62ffd43f0b9bc36d5f7bc0495355
https://pubmed.ncbi.nlm.nih.gov/32627854
https://pubmed.ncbi.nlm.nih.gov/32627854